Business · 03/06/1994Updated: 10/16/2026 · 1 min read
Food and Drug Administration Issues Final Rule for Over-The-Counter Astringent Drug Products
Summary
The Food and Drug Administration (FDA) has issued a final rule updating the monograph for over-the-counter (OTC) astringent drug products, incorporating a United States Pharmacopeia (U.S.P.) name change for an active ingredient.
Original source language: Federal Register — Health and Human ServicesOpen original release →